MATERIAL SAFETY DATA SHEET
Prepared to U.S. OSHA, CMA, ANSI and Canadian WHMIS Standards
PART I What is the material and what do I need to know in an emergency?
1. PRODUCT IDENTIFICATION
TECRON / FLEXRON
TRADE NAME (AS LABELED):
CHEMICAL NAME/CLASS: Neoprene/Inorganic Carbonate Mixture
SYNONYMS: Not applicable
PRODUCT USE: Firestop Product
SUPPLIER/MANUFACTURER'S NAME: Nelson EGS
4135 E. 100th East Ave. #100
ADDRESS:
Tulsa, Oklahoma 74146-3636
CHEMTREC EMERGENCY NO.: 1-800-424-9300 (United States)
BUSINESS PHONE: (918) 627-5530/(800) 331-7325
REVISION DATE: July 14, 2004
2. COMPOSITION and INFORMATION ON INGREDIENTS
CHEMICAL NAME CAS # % w/w EXPOSURE LIMITS IN AIR
ACGIH- TLV OSHA- PEL
TWA STEL TWA STEL IDLH OTHER
3 3 3 3 3 3
mg/m mg/m mg/m mg/m mg/m mg/m
Neoprene 126-99-8 23-35 36 (skin) NE 90 (skin) NE 1086 NIOSH REL:
STEL = 3.5 Ceiling (15 min)
35 (skin)
[vacated 1989 Carcinogen: IARC-2B, MAK-
PEL] 2, NIOSH-X, EPA-D
Magnesium 12072-90-1 11-19 NE NE NE NE NE NE
Carbonate
Kaolin (Clay) 1332-58-7 9-20 2 A4 (Not NE 15 (Total NE NE NIOSH REL:
Classifiable dust), 5 TWA = 10 (Total dust), 5
as a Human (Respirable (Respirable fraction)
Carcinogen) fraction)
[Respirable 10 (Total dust)
fraction] [vacated 1989
PEL]
Calcium Carbonate 471-34-1 8鈥?15 10 NE 15 (Total NE NE NIOSH REL:
[Respirable dust), 5 TWA = 10 (Total dust), 5
fraction] (Respirable (Respirable fraction)
fraction)
Antimony Trioxide 1309-64-4 5鈥?10 0.5 as Sb NE 0.5 as Sb NE 50 as NIOSH REL:
Sb TWA = 0.5 as Sb
Carcinogen: IARC-2B, MAK-
2
NE = Not Established C = Ceiling Limit See Section 16 for Definitions of Terms Used
NOTE: All WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-1998 format.
FLEXRON MSDS
PAGE 1 OF 11
2. COMPOSITION and INFORMATION ON INGREDIENTS (Continued)
CHEMICAL NAME CAS # % w/w EXPOSURE LIMITS IN AIR
ACGIH- TLV OSHA- PEL
TWA STEL TWA STEL IDLH OTHER
3 3 3 3 3 3
mg/m mg/m mg/m mg/m mg/m mg/m
Iron Oxide 1309-37-1 <6 5 A4 (Not NE 10 NE 2500 NIOSH REL:
Classifiable TWA = 5
[exposure limits are for
as a Human
Iron Oxide dust & DFG MAK:
Carcinogen)
fume (Fe2O3), as Fe] TWA = 1.5 (Respirable
[Respirable fraction of the aerosol)
fraction]
Carcinogen: IARC-3
Tritolyl Phosphate 1330-78-5 2-12 NE NE NE NE NE NE
Akrochlor R70 63449-39-8 1鈥?5 NE NE NE NE NE Carcinogen: IARC-2B, NTP-R
Zinc Borate, Hydrate 12447-61-9 1鈥?5 NE NE NE NE NE NE
Magnesium Oxide 1309-48-4 1鈥?5 10 NE 15 (Total 3 750 DFG MAK:
particulate) (vacated TWA = 1.5 (Respirable
(exposure limits are
1989 fraction of the aerosol)
for Magnesium Oxide 1 (vacated
PEL) PEAK = 2鈥AK 5 min
fume) 1989 PEL)
(momentary value)
Zinc Oxide 1314-13-2 1鈥?5 5 10 5 10 500 NIOSH REL:
(vacated TWA = 5
(exposure limits are
1989 STEL = 10
for Zinc Oxide fume)
PEL) DFG MAK:
TWA = 1.5 (Respirable
fraction of the aerosol)
Carcinogen: EPA-D
2-Imidazolidinethione 96-45-7 <1 NE NE NE NE NE NIOSH REL:
Lowest feasible concentration;
use encapsulated form.
Carcinogen: IARC-2B, MAK-
3, NIOSH-X, NTP-R
Other components which are present in Balance None of the other components contribute significant additional hazards at the concentrations
less than 1 percent concentration (0.1% present in this product. All pertinent hazard information has been provided in this document, per
concentration for potential carcinogens, the requirements of the Federal Occupational Safety and Health Administration Standard (29
reproductive toxins, respiratory tract CFR 1910.1200), U.S. State equivalent Standards and Canadian Workplace Hazardous Materials
sensitizers, and mutagens). Identification System Standards (CPR 4).
NE = Not Established C = Ceiling Limit See Section 16 for Definitions of Terms Used
NOTE: All WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-1998 format.
3. HAZARD IDENTIFICATION
EMERGENCY OVERVIEW: This product is a brick red, odorless solid. As a solid, this product does not present a
significant hazard by any route of exposure. If heated to decomposition, the chief health hazard associated with exposure
to fumes would be the potential to slightly irritate the eyes, skin, nose, and other tissues that come in contact with vapors
generated by the product. This product contains components that are known and suspected carcinogens and
reproductive toxins. This product is not flammable or reactive. Thermal decomposition of this product produces irritating
vapors and toxic gases (e.g., calcium oxides, carbon oxides, boron oxides, hydrogen chloride). Emergency responders
must wear proper personal protective equipment for the releases to which they are responding.
SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The most significant route of occupational overexposure
is contact with skin and eyes. The symptoms of overexposure to this product, via route of entry, are as follows:
INHALATION: During heating, breathing vapors given off by this product may irritate the nose, throat, or respiratory system.
Symptoms of such exposure could include coughing and sneezing.
CONTACT WITH SKIN or EYES: Eye contact with the product can cause stinging, tearing, and redness from mechanical
irritation. Skin contact with this product may be slightly irritating, especially after prolonged exposure. (continued on the
following page)
FLEXRON MSDS
PAGE 2 OF 11
3. HAZARD IDENTIFICATION (Continued)
CONTACT WITH SKIN or EYES (continued): Repeated skin contact may
cause dermatitis (red, dry skin). Symptoms are generally alleviated when HAZARDOUS MATERIAL IDENTIFICATION SYSTEM
exposure ends.
SKIN ABSORPTION: Skin absorption is not anticipated to be a significant
HEALTH 2
route of overexposure for any component of this product. (BLUE)
INGESTION: Though not anticipated to be a significant route of
occupational exposure, ingestion of this product (especially in large
FLAMMABILITY
amounts) can irritate the tissues of the mouth, esophagus, and other 0
(RED)
tissues of the digestive system. Symptoms of such overexposure can
include vomiting, diarrhea, and nausea.
INJECTION: Though not anticipated to be a significant route of
REACTIVITY (YELLOW) 0
occupational exposure, injection of this material would cause pain, mild
irritation, and swelling at the site of injection.
PROTECTIVE EQUIPMENT C
HEALTH EFFECTS OR RISKS FROM EXPOSURE: An Explanation in
Lay Terms.
ACUTE: The most likely symptom of acute overexposure would be slight EYES HANDS BODY
RESPIRATORY
to moderate irritation of contaminated skin or eyes after contact with this
product. SEE SECTION 8
CHRONIC: This product contains components that are known and
For routine industrial applications
suspected carcinogens and reproductive toxins. Prolonged or repeated
contact with the skin may cause dermatitis. See Section 11 (Toxicological
Information) for additional data. See Section 16 for Definition of Ratings
TARGET ORGANS: ACUTE: Skin, eyes. CHRONIC: Skin.
PART II What should I do if a hazardous situation occurs?
4. FIRST-AID MEASURES
Contaminated individuals must seek medical attention if any adverse effect occurs. Rescuers should be taken for medical
attention, if necessary. Take a copy of label and MSDS to physician or health professional with the contaminated individual.
SKIN EXPOSURE: If this product contaminates the skin, begin decontamination with copious amounts of running water.
Remove exposed or contaminated clothing, taking care not to contaminate eyes.
EYE EXPOSURE: If the product is contaminates the eyes, open victim's eyes while under gently running water. Use
sufficient force to open eyelids. Have the contaminated individual "roll" eyes. The recommended minimum flushing time is
15 minutes.
INHALATION: If dusts of this product are inhaled, remove victim to fresh air.
INGESTION: If this product is swallowed, CALL PHYSICIAN OR POISON CONTROL CENTER FOR MOST CURRENT
INFORMATION. DO NOT INDUCE VOMITING, unless directed by medical personnel. Have victim rinse mouth with water,
if conscious. Never induce vomiting or give a diluent (e.g., water) to someone who is unconscious, having convulsions, or
unable to swallow.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Preexisting dermatitis, and other skin disorders can be
aggravated by exposure to this product. This product contains components that are known and suspected carcinogens and
reproductive toxins.
RECOMMENDATIONS TO PHYSICIANS: Treat symptoms and eliminate overexposure.
5. FIRE-FIGHTING MEASURES
FLASH POINT: Not applicable.
AUTOIGNITION TEMPERATURE: Not applicable.
FLAMMABLE LIMITS (in air by volume, %):
Lower (LEL): Not applicable.
Upper (UEL): Not applicable.
FLEXRON MSDS
PAGE 3 OF 11
5. FIRE-FIGHTING MEASURES (Continued)
FIRE EXTINGUISHING MATERIALS: Select fire extinguishing media appropriate for the surrounding area.
Water Spray: YES (for cooling) Carbon Dioxide: YES
NFPA RATING
Foam: YES Dry Chemical: YES
Halon: YES Other: Any "ABC" Class. FLAMMABILITY
UNUSUAL FIRE AND EXPLOSION HAZARDS: This product is not
combustible and does not contribute to the intensity of a fire. When involved
0
in a fire, this material may decompose and produce irritating vapors, acrid
smoke, and toxic gases (e.g., calcium oxides, carbon oxides, boron oxides,
0
1
hydrogen chloride). HEALTH REACTIVITY
Explosion Sensitivity to Mechanical Impact: Not sensitive.
Explosion Sensitivity to Static Discharge: Not sensitive.
SPECIAL FIRE-FIGHTING PROCEDURES: Incipient fire responders should
wear eye protection. Structural firefighters must wear Self-Contained
Breathing Apparatus and full protective equipment. Move fire-exposed OTHER
containers if it can be done without risk to firefighters. If possible, firefighters
See Section 16 for
should control runoff water to prevent environmental contamination. Rinse
Definition of Ratings
contaminated equipment with soapy water before returning such equipment to
service.
6. ACCIDENTAL RELEASE MEASURES
RELEASE RESPONSE: Small releases can be cleaned up wearing gloves, goggles, and suitable body protection. In case
of a large spill, clear the affected area, protect people, and respond with trained personnel. Minimum Personal Protective
Equipment should be Level B: triple-gloves (rubber gloves and nitrile gloves over latex gloves), tyvek or lab coat and
boots, dust mask. Self-Contained Breathing Apparatus must be selected if releases which occur in confined or
poorly ventilated areas or in situations in which the level of oxygen is below 19.5.
Pick up spilled solid. Rinse area with soap and water solution and follow with a water rinse. Close off sewers and take other
measures to protect human health and the environment, as necessary. Decontaminate the area thoroughly. Place all spilled
material in an appropriate container and seal. Dispose of in accordance with applicable U.S. Federal, State, or local
procedures, or appropriate Canadian standards (see Section 13, Disposal Considerations).
PART III How can I prevent hazardous situations from occurring?
7. HANDLING and STORAGE
WORK AND HYGIENE PRACTICES: As with all chemicals, avoid getting this product ON YOU or IN YOU. Wash
thoroughly after handling this product. Do not eat, drink, smoke, or apply cosmetics while handling this product. Use in a
well-ventilated location. Remove contaminated clothing immediately.
STORAGE AND HANDLING PRACTICES: All employees who handle this material should be trained to handle it safely.
Open containers slowly on a stable surface. Containers of this product must be properly labeled. Empty containers may
contain residual amounts of this product; therefore, empty containers should be handled with care. Store containers in a
cool, dry location, away from direct sunlight, sources of intense heat, or where freezing is possible. Store away from
incompatible materials (see Section 10, Stability and Reactivity). Material should be stored in secondary containers or in a
diked area as appropriate. Keep container tightly closed when not in use. Inspect all incoming containers before storage to
ensure containers are properly labeled and not damaged.
PROTECTIVE PRACTICES DURING MAINTENANCE OF CONTAMINATED EQUIPMENT: Follow practices indicated in
Section 6 (Accidental Release Measures). Make certain that application equipment is locked and tagged-out safely, if
necessary. Collect all rinsates and dispose of according to applicable U.S. Federal, State, or local procedures and
appropriate Canadian standards.
8. EXPOSURE CONTROLS - PERSONAL PROTECTION
VENTILATION AND ENGINEERING CONTROLS: Use with adequate ventilation to ensure exposure levels are maintained
below the limits provided in Section 2 (Composition and Information on Ingredients) if applicable. Eye wash station/safety
showers should be near locations where this product is used or stored.
RESPIRATORY PROTECTION: None normally required for routine use. Airborne contaminant concentrations must be
maintained below guidelines listed in Section 2 (Composition and Information on Ingredients). If respiratory protection is
needed, use only protection authorized in the U.S. Federal OSHA Standard (29 CFR 1910.134), applicable U.S. State
regulations, or the Canadian CSA Standard Z94.4-93. Oxygen levels below 19.5% are considered IDLH by OSHA. In such
atmospheres, use of a full-facepiece pressure/demand SCBA or a full facepiece, supplied air respirator with auxiliary self-
contained air supply is required under OSHA鈥檚 Respiratory Protection Standard (1910.134-1998).
EYE PROTECTION: Splash goggles or safety glasses.
FLEXRON MSDS
PAGE 4 OF 11
8. EXPOSURE CONTROLS - PERSONAL PROTECTION (Continued)
HAND PROTECTION: Wear Neoprene Rubber gloves for routine industrial use. Use triple gloves for spill response, as
stated in Section 6 (Accidental Release Measures) of this MSDS.
BODY PROTECTION: Use body protection appropriate for task.
9. PHYSICAL and CHEMICAL PROPERTIES
RELATIVE VAPOR DENSITY (air = 1): Not applicable. EVAPORATION RATE (n-BuAc = 1): Not applicable.
SPECIFIC GRAVITY (water = 1): Not established. MELTING/FREEZING POINT: > 1000掳C (1832掳F)
SOLUBILITY IN WATER: Insoluble BOILING POINT: Not established.
VAPOR PRESSURE, mm Hg @ 20掳C: Not applicable. pH: Not applicable.
PARTITION COEFFICIENT (n-octanol/water): Not applicable.
ODOR THRESHOLD: Not established.
APPEARANCE, ODOR and COLOR: This is brick red, odorless solid.
HOW TO DETECT THIS SUBSTANCE (warning properties): The appearance may act as a distinguishing characteristic for
this product.
10. STABILITY and REACTIVITY
STABILITY: Stable.
DECOMPOSITION PRODUCTS: Thermal decomposition can generate calcium oxides, carbon oxides, boron oxides, and
hydrogen chloride.
MATERIALS WITH WHICH SUBSTANCE IS INCOMPATIBLE: Strong acids, strong bases, strong oxidizers.
HAZARDOUS POLYMERIZATION: Will not occur.
CONDITIONS TO AVOID: Avoid exposure or contact to extreme temperatures, incompatible chemicals.
PART IV Is there any other useful information about this material?
11. TOXICOLOGICAL INFORMATION
TOXICITY DATA: The specific toxicology data available for components greater than 1% in concentration are as follows.
AKROCHLOR R70: Currently, there are no ANTIMONY TRIOXIDE (continued): MAGNESIUM OXIDE:
3
toxicological data available for this TDLo (subcutaneous, rat) = 25688 mg/kg/13 TCLo (inhalation, human) = 400 mg/m
3
TCLo (inhalation, rat) = 1120 碌g/m /24 hours/29
compound. weeks/intermittent; Cardiac: other changes
TDLo (intratesticular, rat) = 23320 碌g/kg/male 1 days/continuous; Brain and Coverings:
ANTIMONY TRIOXIDE:
day pre-mating; Reproductive: Paternal recordings from specific areas of CNS; Blood:
Gene Conversion and Mitotic Recombination
Effects: spermatogenesis (incl. genetic changes in serum composition (e.g. TP,
(Bacillus subtilis) = 50 mmol/L
material, sperm morphology, motility, and bilirubin, cholesterol); Biochemical: Enzyme
Sister Chromatid Exchange (lung, hamster) = 90
count), testes, epididymis, sperm duct. inhibition, induction, or change in blood or
mg/L 3
TCLo (inhalation, guinea pig) = 45 mg/m /10 tissue levels: true cholinesterase
Eye Irritancy (rabbit) = 100 mg; Mild
weeks/intermittent; Lungs, Thorax, or TDLo (intratracheal, hamster) = 480 mg/kg/30
3
TCLo (inhalation, rat) = 72 碌g/m /24 hours/17
Respiration - fibrosis, focal (pneumoconiosis); weeks/intermittent; Equivocal tumorigenic
weeks/continuous; Blood: pigmented or
Liver: fatty liver degeneration; Related to agent
nucleated red blood cells; Biochemical:
Chronic Data: death
Enzyme inhibition, induction, or change in NEOPRENE:
LD50 (oral, rat) > 20 g/kg
blood or tissue levels: true cholinesterase, Mutation in Microorganisms (Salmonella
LD50 (oral, rat) > 34600 mg/kg; Somnolence typhimurium) = 70 碌mol/L
Metabolism (Intermediary) - lipids including
(general depressed activity); Skin and
transport Mutation in Microorganisms (Salmonella
Appendages: hair
3
TCLo (inhalation, rat) = 270 mg/m /1鈥?21 days typhimurium) = 2 pph/4 hours
LD50 (subcutaneous, rat) = 7904 mg/kg
post; Teratogenic effects Sex Chromosome Loss and Nondisjunction
LD50 (intraperitoneal, rat) = 3250 mg/kg
3
TCLo (inhalation, rat) = 270 mg/m /1鈥?21 days (oral, Drosophila )= 5700 碌mol/L/3
LD50 (intraperitoneal, mouse) = 172 mg/kg
post; Reproductive effects days/intermittent
LDLo (skin, rabbit) = 2 g/kg
3
TCLo (inhalation, rat) = 4200 mg/m /52 Cytogenetic Analysis (unreported, human) = 1
LDLo (subcutaneous, rabbit) = 2500 mg/kg
weeks/intermittent; Carcinogenic effects 3
mg/m
LDLo (intravenous, dog) = 3 mg/kg
3
TCLo (inhalation, rat) = 82 碌g/m /female 1鈥?21 Cytogenetic Analysis (inhalation, rat) = 1960
CALCIUM CARBONATE: Currently, there are no
days after conception; Reproductive: Fertility: 3
碌g/m /16 weeks
toxicological data available for this
pre-implantation mortality (e.g. reduction in Cytogenetic Analysis (inhalation, mouse) = 320
compound.
number of implants per female; total number 3
碌g/m /4 weeks/continuous
of implants per corpora lutea), Effects on IRON OXIDE: Dominant Lethal Test (inhalation, rat) = 4
Embryo or Fetus: fetotoxicity (except death, TDLo (subcutaneous, rat) = 135 mg/kg; Equivocal 碌g/L/48 days/intermittent
e.g., stunted fetus) tumorigenic agent Micronucleus Test (inhalation, mouse) = 1480
3
TC (inhalation, rat) = 4 mg/m /1 years/intermittent; 3
LD50 (intraperitoneal, rat) = 5500 mg/kg ug/m /2 hours/2 days/intermittent
Equivocal tumorigenic agent LD50 (intraperitoneal, mouse) = 5400 mg/kg Morphological Transformation (hamster,
3
TC (inhalation, rat) = 1600 mg/m /52 LDLo (subcutaneous, dog) = 30 mg/kg embryo) = 125 mg/L
weeks/intermittent; Neoplastic effects KAOLIN:
3
TC (inhalation, rat) = 50 mg/m /7 hours/52 TDLo (oral, rat) = 590 g/kg/female 37 days pre;
weeks/intermittent; Carcinogenic effects Reproductive effects
MAGNESIUM CARBONATE: Currently, there
are no toxicological data available for this
compound.
FLEXRON MSDS
PAGE 5 OF 11
11. TOXICOLOGICAL INFORMATION (Continued)
TOXICITY DATA (continued):
NEOPRENE (continued): NEOPRENE (continued): TRITOLYL PHOSPHATE (continued):
3
Standard Draize Test (skin, rabbit) = 500 碌L/24 TCLo (inhalation, rat) = 4 mg/m /24 Standard Draize Test (eye, rabbit) = 500 mg/24
hours/female 11鈥?12 days after conception; hours; Mild
hours; Severe
Reproductive: Specific Developmental TDLo (oral, woman) 70 mg/kg/14 days;
碌g/kg/26
TDLo (oral, rat) = 9100
Abnormalities: Central Nervous System Peripheral Nerve and Sensation: flaccid
weeks/intermittent; Changes in liver weight;
TCLo (inhalation, rat) = 10 ppm/4 hours/female paralysis without anesthesia (usually
Changes in spleen weight; Enzyme
3鈥?20 days after conception; Reproductive: neuromuscular blockage); Behavioral:
inhibition, induction, or change in blood or
Fertility: post-implantation mortality (e.g. changes in motor activity (specific assay),
tissue levels: dehydrogenases
dead and/or resorbed implants per total muscle weakness
TDLo (oral, rat) = 9100 碌g/kg/male 26 weeks
number of implants) TDLo (oral, rat) = 20,300 mg/kg/16
pre-mating; Reproductive: Paternal Effects: 3
TCLo (inhalation, rat) = 150 ug/m /24 days/intermittent; Behavioral: changes in
spermatogenesis (incl. genetic material,
hours/male 19 weeks pre-mating; motor activity (specific assay); Endocrine:
sperm morphology, motility, and count)
Reproductive: Paternal Effects: changes in thymus weight; Nutritional and
TDLo (oral, rat) = 1680 mg/kg/3
spermatogenesis (incl. genetic material, Gross Metabolic: weight loss or decreased
weeks/intermittent; Liver: hepatitis
sperm morphology, motility, and count) weight gain
(hepatocellular necrosis), diffuse, other 3
TCLo (inhalation, rat) = 500 mg/m /5 TDLo (oral, rat) = 23,400 mg/kg/13
changes; Biochemical: Enzyme inhibition,
hours/female 17 weeks pre-mating; weeks/intermittent; Liver: changes in liver
induction, or change in blood or tissue
Reproductive: Menstrual cycle changes or weight; Kidney, Ureter, Bladder: changes in
levels: hepatic microsomal mixed oxidase
disorders bladder weight; Blood: changes in serum
(dealkylation, hydroxylation, etc.) 3
TCLo (inhalation, rat) = 500 mg/m /5 composition (e.g. TP, bilirubin, cholesterol)
TDLo (oral, rat) = 1 mg/kg/female 11鈥?12 days
hours/female 30 weeks pre-mating; TDLo (oral, rat) = 252 mg/kg/6 weeks/continuous;
after conception/ Reproductive: Specific
Reproductive: Maternal Effects: ovaries, Immunological Including Allergic: decrease in
Developmental Abnormalities: Central
fallopian tubes cellular immune response, decrease in
Nervous System, Effects on Embryo or
TCLo (inhalation, mouse) = 32 ppm/6 hours/2 humoral immune response
Fetus: fetotoxicity (except death, e.g.,
years/intermittent; Tumorigenic: TDLo (oral, rat) = 24 g/kg/60 days/intermittent;
stunted fetus)
Carcinogenic by RTECS criteria; Liver: Endocrine: other changes
TDLo (oral, rat) = 1 mg/kg/female 9鈥?10 days
tumors; Lungs, Thorax, or Respiration: TDLo (oral, rat) = 4550 mg/kg/male 13 weeks
after conception; Reproductive: Specific
tumors pre-mating; Reproductive: Paternal Effects:
Developmental Abnormalities: other 3
TCLo (inhalation, mouse) = 1260 mg/m /14 spermatogenesis (incl. genetic material,
developmental abnormalities
days/intermittent; Endocrine: changes in sperm morphology, motility, and count),
3
TDLo (oral, mouse) = 63 mg/m /21
thymus weight; Immunological Including testes, epididymis, sperm duct
days/intermittent; Immunological Including
Allergic: decrease in cellular immune, TDLo (oral, rat) = 13,200 mg/kg/male 66 days
Allergic: decreased immune response
decrease in humoral immune pre-mating; Reproductive: Paternal Effects:
TDLo (subcutaneous , mouse) = 42 mg/kg/21 3
TCLo (inhalation, mouse) = 200 mg/m /24 spermatogenesis (incl. genetic material,
days/intermittent:; Immunological Including
hours/91 days/continuous; Gastrointestinal: sperm morphology, motility, and count),
Allergic: decreased immune response;
ulceration or bleeding from large intestine; testes, epididymis, sperm duct
Biochemical: Metabolism (Intermediary):
Blood: changes in spleen; Related to TDLo (oral, rat) = 16 g/kg/male 66 days pre-
other proteins
Chronic Data: death mating/female 24 days pre-mating, 22 days
TCLo (inhalation, rat) = 161 ppm/6 hours/4
TCLo (inhalation, hamster) = 162 ppm/6 hours/4 after conception; Reproductive: fetal death
weeks/intermittent; Liver: changes in liver
weeks/intermittent; Liver: hepatitis TDLo (oral, mouse) = 1750 mg/kg/male 7 days
weight; Kidney, Ureter, Bladder: changes in
(hepatocellular necrosis), zonal; Nutritional pre-mating; Reproductive: Paternal Effects:
bladder weight; Nutritional and Gross
and Gross Metabolic: weight loss or spermatogenesis (incl. genetic material,
Metabolic: weight loss or decreased weight
decreased weight gain; Related to Chronic sperm morphology, motility, and count),
gain
Data: death testes, epididymis, sperm duct; Effects on
3
TCLo (inhalation, rat) = 220 碌g/m /24 hours/60
TCLo (inhalation, hamster) = 50 ppm/6 hours/78 Newborn: live birth index (measured after
days/continuous; Brain and Coverings:
weeks/intermittent; Nutritional and Gross birth)
other degenerative changes; Liver: other
Metabolic: weight loss or decreased weight TDLo (oral, mouse) = 4464 mg/kg/male 7 days
changes; Induction, or change in blood or
gain pre-mating/female 7 days pre-mating, 22
tissue levels: phosphatases
LD50 (oral, rat) = 450 mg/kg days after conception; Reproductive: Effects
3
TCLo (inhalation, rat) = 200 mg/m /24 hours/91 3
LC50 (inhalation, rat) = 11,800 mg/m /4 hours on Newborn: growth statistics (e.g.%,
days/continuous; Brain and Coverings:
LDLo (subcutaneous, rat) = 500 mg/kg; reduced weight gain)
other degenerative changes;
Behavioral: convulsions or effect on seizure TDLo (oral, mouse) = 7250 mg/kg/female 7 days
Gastrointestinal: ulceration or bleeding from
threshold; Lungs, Thorax, or Respiration: pre-mating/female 1鈥?22 days after
large intestine; Blood: changes in spleen
dyspnea, cyanosis conception; Reproductive: Effects on
TCLo (inhalation, rat) = 50 ppm/6 hours/2
LD50 (oral, mouse) = 146 mg/kg Newborn: live birth index (measured after
years/intermittent; Changes in lung weight; 3
LC50 (inhalation, mouse) = 23,000 mg/m birth)
Skin and Appendages: hair; Nutritional and
LDLo (subcutaneous, mouse) = 1 g/kg; TDLo (oral, mouse) = 2250 mg/kg/male 7 days
Gross Metabolic: weight loss or decreased
Behavioral: convulsions or effect on seizure pre-mating /female 7 days pre-mating, 22
weight gain
threshold; Lungs, Thorax, or Respiration: days after conception; Reproductive: Effects
TCLo (inhalation, rat) = 32 ppm/6 hours/16
dyspnea, cyanosis on Newborn: germ cell effects (in offspring)
days/intermittent; Sense Organs and
LDLo (subcutaneous, cat) = 100 mg/kg TDLo (oral, mouse) = 52 g/kg/13
Special Senses (Olfaction): effect, not 3
LCLo (inhalation, cat) = 1290 mg/m /8 hours weeks/intermittent; Somnolence (general
otherwise specified
LDLo (subcutaneous, pigeon) = 13 g/kg depressed activity); Changes in serum
TCLo (inhalation, rat) = 80 ppm/6 hours/2
LDLo (intravenous, rabbit) = 96 mg/kg; Blood: composition (e.g. TP, bilirubin, cholesterol);
years/intermittent; Tumorigenic:
other changes; Skin and Appendages: Enzyme inhibition, induction, or change in
Carcinogenic by RTECS criteria; Sense
dermatitis, other (after systemic exposure) blood or tissue levels: true cholinesterase
Organs and Special Senses (Olfaction): 3
LCLo (inhalation, rabbit) = 3870 mg/ m /8 hours
tumors
3
TRITOLYL PHOSPHATE:
TCLo (inhalation, rat) = 4 mg/m /24
Open Irritation Test (skin, rabbit) = 500 mg; Mild
hours/female 3鈥?4 days after conception;
Effects on Embryo or Fetus: fetal death
FLEXRON MSDS
PAGE 6 OF 11
11. TOXICOLOGICAL INFORMATION (Continued)
TOXICITY DATA (continued):
TRITOLYL
PHOSPHATE (continued): TRITOLYL PHOSPHATE (continued): ZINC OXIDE (continued):
3
TDLo (oral, mouse) = 10,220 mg/kg/16 LDLo (skin, rabbit) = 1 g/kg; Gastrointestinal: TCLo (inhalation, human) = 600 mg/m ; cough,
days/intermittent; Behavioral: changes in changes in structure or function of salivary dyspnea, other changes
motor activity (specific assay); Liver: changes glands, hypermotility, diarrhea; Inhibition, TDLo (oral, rat) = 17431 mg/kg/90
in liver weight; Nutritional and Gross induction, or change in blood or tissue levels: days/continuous; Behavioral: changes in
Metabolic: weight loss or decreased weight true cholinesterase motor activity (specific assay)
3
TCLo (inhalation, guinea pig) = 5900 碌g/m /3
gain ZINC BORATE, HYDRATE:
TDLo (oral, cat) = 2100 mg/kg/6 hours/3 days/intermittent; change in blood
Currently, there are no toxicological data
weeks/intermittent; Tremor, excitement; or tissue levels: phosphatases,
available for this compound.
Related to Chronic Data: death dehydrogenases
ZINC OXIDE: 3
LDLo (oral, human) = 1800 mg/kg TCLo (inhalation, guinea pig) = 4600 ug/m /3
DNA Adduct (Escherichia coli) = 3000 ppm
LD50 (oral, rat) = 3 g/kg hours/6 days/intermittent; other changes,
Cytogenetic Analysis (inhalation, rat) = 100
LD50 (oral, mouse) = 3900 mg/kg changes in lung weight
3
碌g/m
LDLo (subcutaneous, mouse) = 12 mg/kg; TDLo (oral, chicken) = 32,203 mg/kg/4
Morphological Transformation (embryo,
Peripheral Nerve and Sensation: spastic weeks/continuous; changes in growth
hamster) = 1 mg/L
paralysis with or without sensory change; hormone; evidence of thyroid hypofunction;
Unscheduled DNA Synthesis (embryo, hamster)
Behavioral: somnolence (general depressed weight loss or decreased weight gain
= 1 mg/L
activity); Lungs, Thorax, or Respiration: TDLo (oral, domestic mammal) = 3584 mg/kg/4
Unscheduled DNA synthesis (inhalation, guinea
cyanosis weeks/intermittent; changes in structure or
3
pig) = 5300 ug/m /3 hours/6 days
LD50 (oral, chicken) > 10 g/kg function of endocrine pancreas; changes in
Sister Chromatid Exchange (embryo, hamster)
LD50 (skin, cat) = 1500 mg/kg; Peripheral Nerve serum composition; changes in metals, not
= 300 碌g/L
and Sensation: flaccid paralysis without otherwise specified
Standard Draize Test (eye, rabbit) = 500 mg/24
anesthesia (usually neuromuscular LDLo (oral, human) = 500 mg/kg
hours; mild
blockage); Behavioral: ataxia LD (oral, rat) > 8437 mg/kg
TDLo (oral, rat) = 6846 mg/kg/female 1鈥?22 days
LDLo (oral, rabbit) = 100 mg/kg LD50 (intraperitoneal, rat) 240 mg/kg
after conception; Reproductive: Specific
LD50 (parenteral, rabbit) = 100 mg/kg LD50 (oral, mouse) = 7950 mg/kg
Developmental Abnormalities: homeostasis; 3
LDLo (oral, dog) = 500 mg/kg LC50 (inhalation, mouse) = 2500 mg/m
stillbirth; Effects on Newborn: growth
statistics
SUSPECTED CANCER AGENT: Components of this product are listed by agencies as follows:
Akrochlor R70: IARC-2B (Possibly Carcinogenic to Humans); NTP-R, Reasonably Anticipated to be a Human
Carcinogen.
Antimony Trioxide: IARC-2B (Possibly Carcinogenic to Humans; MAK-2 (Substances that are Considered to be
Carcinogenic to Man).
2-Imidazolinethione: IARC-2B (Possibly Carcinogenic to Humans); NTP-R (Reasonably Anticipated to be a Human
Carcinogen); NIOSH-X (Carcinogen Defined with no Further Categorization); MAK-3 (Substances that cause concern
that they could be carcinogenic for man)
Iron Oxide: IARC-3 (Unclassifiable as to Carcinogenicity in Humans); TLV-A4 (Not Classifiable as a Human Carcinogen)
Kaolin: TLV-A4, Not Classifiable as a Human Carcinogen
Neoprene: IARC-2B (Possibly Carcinogenic to Humans); MAK-2 ( Substances that are considered to be carcinogenic to
man); NIOSH-X (Carcinogen Defined with no Further Categorization); EPA-D (Not Classifiable as to human
Carcinogenicity)
Zinc Oxide: EPA-D (Not Classifiable as to Human Carcinogenicity)
IRRITANCY OF PRODUCT: This product may be slightly irritating to contaminated tissue, especially after prolonged or
repeated exposure.
SENSITIZATION TO THE PRODUCT: The components of this product are not known to be sensitizers with repeated or
prolonged use.
REPRODUCTIVE TOXICITY INFORMATION: Listed below is information concerning the effects of this product and its
components on the human reproductive system.
Mutagenicity: This product is not reported to produce mutagenic effects in humans. Human mutation data are available
for Neoprene (a component of this product); these data were obtained during clinical studies on specific human tissues
exposed to high doses of this compound. Animal mutation data are available for Antimony Oxide, 2-Imidazolinethione,
and Zinc Oxide (components of this product); these data were obtained during clinical studies on specific animal tissues
exposed to high doses of these compounds.
Embryotoxicity: This product is not reported to produce embryotoxic effects in humans.
Teratogenicity: This product is not reported to cause teratogenic effects in humans. Clinical studies on test animals
exposed to relatively high doses of Antimony Oxide, Neoprene, 2-Imidazolinethione, Tritolyl Phosphate, and Zinc Oxide
(components of this product) provided teratogenic data.
Reproductive Toxicity: This product is not reported to cause reproductive effects in humans. Clinical studies on test
animals exposed to relatively high doses of Antimony Oxide, Neoprene, 2-Imidazolinethione, Tritolyl Phosphate, and Zinc
Oxide (components of this product) provided reproductive toxicity data.
FLEXRON MSDS
PAGE 7 OF 11
11. TOXICOLOGICAL INFORMATION (Continued)
A mutagen is a chemical which causes permanent changes to genetic material (DNA) such that the changes will propagate
through generational lines. An embryotoxin is a chemical which causes damage to a developing embryo (i.e. within the first
eight weeks of pregnancy in humans), but the damage does not propagate across generational lines. A teratogen is a
chemical which causes damage to a developing fetus, but the damage does not propagate across generational lines. A
reproductive toxin is any substance which interferes in any way with the reproductive process.
ACGIH BIOLOGICAL EXPOSURE INDICES: Currently, there are no ACGIH Biological Exposure Indices (BEIs) associated
with the components of this product.
12. ECOLOGICAL INFORMATION
ALL WORK PRACTICES MUST BE AIMED AT ELIMINATING ENVIRONMENTAL CONTAMINATION.
ENVIRONMENTAL STABILITY: This product will persist in the environment.
EFFECT OF MATERIAL ON PLANTS or ANIMALS: This product may be harmful to contaminated plant and animal-life
(especially if large quantities are released). Refer to Section 11 (Toxicological Information) for additional information on
effects on animals.
EFFECT OF CHEMICAL ON AQUATIC LIFE: This product may be harmful to contaminated aquatic plant and animal life.
13. DISPOSAL CONSIDERATIONS
PREPARING WASTES FOR DISPOSAL: Waste disposal must be in accordance with appropriate U.S. Federal, State, and
local regulations or with regulations of Canada and its Provinces. This product, if unaltered by use, may be disposed of by
treatment at a permitted facility or as advised by your local hazardous waste regulatory authority.
U.S. EPA WASTE NUMBER: Not applicable.
14. TRANSPORTATION INFORMATION
THIS MATERIAL IS NOT HAZARDOUS AS DEFINED BY 49 CFR 172.101 BY THE U.S. DEPARTMENT OF
TRANSPORTATION.
PROPER SHIPPING NAME: Not applicable.
HAZARD CLASS NUMBER and DESCRIPTION: Not applicable.
UN IDENTIFICATION NUMBER: Not applicable.
PACKING GROUP: Not applicable.
DOT LABEL(S) REQUIRED: Not applicable.
NORTH AMERICAN EMERGENCY RESPONSE GUIDEBOOK NUMBER (1996): Not applicable.
MARINE POLLUTANT: This product is not designated by the DOT to be a Marine Pollutant (49 CFR 172.101, Appendix
B).
TRANSPORT CANADA TRANSPORTATION OF DANGEROUS GOODS REGULATIONS: This material is not considered
as dangerous goods by Transport Canada.
IATA DESIGNATION: This material is not considered as dangerous goods by the International Air Transport Association.
UPS SHIPPING: This material is not considered as Hazardous Materials by the United Parcel Service.
15. REGULATORY INFORMATION
ADDITIONAL U.S. REGULATIONS:
U.S. SARA REPORTING REQUIREMENTS: The components of this product are subject to the reporting requirements of
Sections 302, 304, and 313 of Title III of the Superfund Amendments and Reauthorization Act as follows:
CHEMICAL NAME SARA 302 SARA 304 SARA 313
(40 CFR 355, Appendix A) (40 CFR Table 302.4) (40 CFR 372.65)
Antimony Trioxide No Yes Yes
2-Imidazolinethione No Yes Yes
Neoprene No Yes Yes
Zinc Oxide No Yes (as a Zinc Compound) Yes
U.S. SARA THRESHOLD PLANNING QUANTITY: There are no specific Threshold Planning Quantities for the components
of this product. The default Federal MSDS submission and inventory requirement filing threshold of 10,000 lb (4,540 kg) may
apply, per 40 CFR 370.20.
U.S. CERCLA REPORTABLE QUANTITY (RQ): Antimony Trioxide = 1000 lb (454 kg); 2-Imidazolinethione = 10 lb (4.5 kg);
Neoprene = 100 lb (45.4 kg).
U.S. TSCA INVENTORY STATUS: The components of this product are listed on the TSCA Inventory.
FLEXRON MSDS
PAGE 8 OF 11
OTHER U.S. FEDERAL REGULATIONS: Not applicable.
FLEXRON MSDS
PAGE 9 OF 11
15. REGULATORY INFORMATION (Continued)
U.S. STATE REGULATORY INFORMATION: Components of this product are covered under specific State regulations, as
denoted below:
Alaska - Designated Toxic and Hazardous Michigan - Critical Materials Register: Pennsylvania - Hazardous Substance List:
Antimony Compounds, 2-Imidazolinethione, Antimony Trioxide, 2-Imidazolinethione, Iron
Substances: Iron Oxide, Magnesium Oxide
Neoprene, Zinc Compounds. Oxide, Kaolin, Magnesium Oxide, Neoprene,
Fume, Neoprene, Zinc Oxide Fume.
Zinc Oxide.
Minnesota - List of Hazardous Substances:
California - Permissible Exposure Limits for
Antimony Trioxide, Iron Oxide, Kaolin, Rhode Island - Hazardous Substance List:
Chemical Contaminants: Calcium
Magnesium Oxide Fume, Neoprene, Zinc Antimony Trioxide, 2-Imidazolinethione, Iron
Carbonate, Iron Oxide, Kaolin, Magnesium
Oxide Fume. Oxide, Magnesium Oxide Fume, Neoprene,
Oxide Fume, Neoprene, Zinc Oxide Fume.
Zinc Oxide.
Missouri - Employer Information/Toxic
Florida - Substance List: Antimony Trioxide, 2-
Texas - Hazardous Substance List: Iron Oxide,
Substance List: Antimony Trioxide, Iron
Imidazolinethione, Iron Oxide, Magnesium
Magnesium Oxide Fume, Neoprene, Zinc
Oxide, Kaolin, Magnesium Oxide, Neoprene,
Oxide Fume, Neoprene, Zinc Oxide Fume.
Oxide Fume.
Zinc Oxide.
Illinois - Toxic Substance List: 2-
West Virginia - Hazardous Substance List:
New Jersey - Right to Know Hazardous
Imidazolinethione, Iron Oxide, Kaolin,
Iron Oxide, Magnesium Oxide Fume,
Magnesium Oxide Fume, Zinc Oxide Fume. Substance List: Antimony Trioxide, 2-
Neoprene, Zinc Oxide Fume.
Imidazolinethione, Iron Oxide, Magnesium
Kansas - Section 302/313 List: 2-
Wisconsin - Toxic and Hazardous
Oxide, Neoprene, Zinc Oxide Fume.
Imidazolinethione, Neoprene.
Substances: Iron Oxide, Magnesium Oxide
North Dakota - List of Hazardous Chemicals,
Massachusetts - Substance List: Antimony
Fume, Neoprene, Zinc Oxide Fume.
Trioxide, 2-Imidazolinethione, Iron Oxide, Reportable Quantities: Antimony Trioxide,
Magnesium Oxide Fume, Neoprene, Zinc 2-Imidazolinethione.
Oxide Fume.
CALIFORNIA SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT (PROPOSITION 65): Antimony Trioxide, and
2-Imidazolinethione (components of this product) are on the California Proposition 65 lists. WARNING! This product
contains chemicals known to the State of California to cause cancer, birth defects, and other reproductive harm.
ANSI LABELING (Z129.1): WARNING! CONTAINS KNOWN AND POTENTIAL CARCINOGENS. MAY CAUSE
REPRODUCTIVE HARM. MAY IRRITATE SKIN AND EYES. MAY BE HARMFUL IF INGESTED OR INHALED. Avoid
contact with skin, eyes, or clothing. Wash thoroughly after handling. Work in well-ventilated area. Do not taste or swallow.
Wear gloves, goggles, and appropriate body protection. FIRST-AID: In case of contact with skin or eyes, flush skin with
plenty of water for 15 minutes. If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is
difficult, give oxygen. If swallowed, do not induce vomiting. Get medical attention if adverse effects develop. IN CASE OF
FIRE: Use water fog, dry chemical, CO2, or "alcohol" foam. IN CASE OF SPILL: Pick up carefully. For large spills, dike
area. Consult Material Safety Data Sheet for additional information.
ADDITIONAL CANADIAN REGULATIONS:
CANADIAN DSL/NDSL INVENTORY STATUS: The components of this product are listed on the DSL/NDSL Inventory.
OTHER CANADIAN REGULATIONS: Not applicable.
CANADIAN ENVIRONMENTAL PROTECTION ACT (CEPA) PRIORITY SUBSTANCES LISTS: The components of this
product are not on the CEPA Priority Substances Lists.
CANADIAN WHMIS SYMBOLS: Class D2A [Material Causing Other Toxic Effect, based on IARC classification 2B for
Antimony Trioxide, Akrochlor R70, 2-Imidazolinethione, and Neoprene (components of this product)]
16. OTHER INFORMATION
PREPARED BY: CHEMICAL SAFETY ASSOCIATES, Inc.
9163 Chesapeake Drive, San Diego, CA 92123-1002
(619) 565 - 0302
DATE OF PRINTING: July 15, 2004
The information contained herein is based on data considered accurate. However, no warranty is expressed or implied regarding the accuracy of
these data or the results to be obtained from the use thereof. Nelson EGS assumes no responsibility for injury to the vendee or third persons
proximately caused by the material if reasonable safety procedures are not adhered to as stipulated in the data sheet. Additionally, Nelson EGS
assumes no responsibility for injury to vendee or third persons proximately caused by abnormal use of the material even if reasonable safety
procedures are followed. Furthermore, vendee assumes the risk in his use of the material.
FLEXRON MSDS
PAGE 10 OF 11
DEFINITIONS OF TERMS
A large number of abbreviations and acronyms appear on a MSDS. Some of these which are commonly used include the following:
CAS #: This is the Chemical Abstract Service Number which uniquely identifies each constituent. It is used for computer-related searching.
EXPOSURE LIMITS IN AIR: FLAMMABILITY LIMITS IN AIR:
Much of the information related to fire and explosion is derived from the
ACGIH - American Conference of Governmental Industrial Hygienists, a
National Fire Protection Association (NFPA). Flash Point - Minimum
professional association which establishes exposure limits. TLV -
temperature at which a liquid gives off sufficient vapors to form an ignitable
Threshold Limit Value - an airborne concentration of a substance which
mixture with air. Autoignition Temperature: The minimum temperature
represents conditions under which it is generally believed that nearly all
required to initiate combustion in air with no other source of ignition. LEL -
workers may be repeatedly exposed without adverse effect. The duration
the lowest percent of vapor in air, by volume, that will explode or ignite in the
must be considered, including the 8-hour Time Weighted Average (TWA),
presence of an ignition source. UEL - the highest percent of vapor in air, by
the 15-minute Short Term Exposure Limit, and the instantaneous Ceiling
volume, that will explode or ignite in the presence of an ignition source.
Level (C). Skin absorption effects must also be considered.
OSHA - U.S. Occupational Safety and Health Administration.
TOXICOLOGICAL INFORMATION:
PEL - Permissible Exposure Limit - This exposure value means exactly the
Human and Animal Toxicology: Possible health hazards as derived from
same as a TLV, except that it is enforceable by OSHA. The OSHA
human data, animal studies, or from the results of studies with similar
Permissible Exposure Limits are based in the 1989 PELs and the June,
compounds are presented. Definitions of some terms used in this section
1993 Air Contaminants Rule (Federal Register: 58: 35338-35351 and 58:
are: LD50 - Lethal Dose (solids & liquids) which kills 50% of the exposed
40191). Both the current PELs and the vacated PELs are indicated. The
animals; LC50 - Lethal Concentration (gases) which kills 50% of the exposed
phrase, 鈥淰acated 1989 PEL,鈥? is placed next to the PEL which was vacated
animals; ppm concentration expressed in parts of material per million parts
by Court Order. IDLH - Immediately Dangerous to Life and Health - This 3
of air or water; mg/m concentration expressed in weight of substance per
level represents a concentration from which one can escape within 30-
volume of air; mg/kg quantity of material, by weight, administered to a test
minutes without suffering escape-preventing or permanent injury. The DFG -
subject, based on their body weight in kg. Other measures of toxicity include
MAK is the Republic of Germany鈥檚 Maximum Exposure Level, similar to the
TDLo, the lowest dose to cause a symptom and TCLo the lowest
U.S. PEL. NIOSH is the National Institute of Occupational Safety and
concentration to cause a symptom; TDo, LDLo, and LDo, or TC, TCo,
Health, which is the research arm of the U.S. Occupational Safety and
LCLo, and LCo, the lowest dose (or concentration) to cause lethal or toxic
Health Administration (OSHA). NIOSH issues exposure guidelines called
effects. Cancer Information: The sources are: IARC - the International
Recommended Exposure Levels (RELs). When no exposure guidelines are
Agency for Research on Cancer; NTP - the National Toxicology Program,
established, an entry of NE is made for reference.
RTECS - the Registry of Toxic Effects of Chemical Substances, OSHA and
HAZARD RATINGS: CAL/OSHA. IARC and NTP rate chemicals on a scale of decreasing
HAZARDOUS MATERIALS IDENTIFICATION SYSTEM: Health Hazard: 0 potential to cause human cancer with rankings from 1 to 4. Subrankings
(minimal acute or chronic exposure hazard); 1 (slight acute or chronic (2A, 2B, etc.) are also used. Other Information: BEI - ACGIH Biological
Exposure Indices, represent the levels of determinants which are most likely
exposure hazard); 2 (moderate acute or significant chronic exposure
to be observed in specimens collected from a healthy worker who has been
hazard); 3 (severe acute exposure hazard; onetime overexposure can result
exposed to chemicals to the same extent as a worker with inhalation
in permanent injury and may be fatal); 4 (extreme acute exposure hazard;
exposure to the TLV. Ecological Information: EC is the effect
onetime overexposure can be fatal). Flammability Hazard: 0 (minimal
concentration in water. BCF = Bioconcentration Factor, which is used to
hazard); 1 (materials that require substantial pre-heating before burning); 2
determine if a substance will concentrate in lifeforms which consume
(combustible liquid or solids; liquids with a flash point of 38-93掳C [100-
contaminated plant or animal matter. Coefficient of Oil/Water Distribution
200掳F]); 3 (Class IB and IC flammable liquids with flash points below 38掳C
is represented by log Kow or log Koc and is used to assess a substance鈥檚
[100掳F]); 4 (Class IA flammable liquids with flash points below 23掳C [73掳F]
behavior in the environment.
and boiling points below 38掳C [100掳F]. Reactivity Hazard: 0 (normally
stable); 1 (material that can become unstable at elevated temperatures or REGULATORY INFORMATION:
which can react slightly with water); 2 (materials that are unstable but do not This section explains the impact of various laws and regulations on the
detonate or which can react violently with water); 3 (materials that can material. U.S.: EPA is the U.S. Environmental Protection Agency. DOT is
detonate when initiated or which can react explosively with water); 4 the U.S. Department of Transportation. SARA is the Superfund
(materials that can detonate at normal temperatures or pressures). Amendments and Reauthorization Act. TSCA is the U.S. Toxic Substance
NATIONAL FIRE PROTECTION ASSOCIATION: Health Hazard: 0 Control Act. CERCLA (or Superfund) refers to the Comprehensive
(material that on exposure under fire conditions would offer no hazard Environmental Response, Compensation, and Liability Act. Labeling is per
beyond that of ordinary combustible materials); 1 (materials that on the American National Standards Institute (ANSI Z129.1). CANADA:
exposure under fire conditions could cause irritation or minor residual injury); CEPA is the Canadian Environmental Protection Act. WHMIS is the
2 (materials that on intense or continued exposure under fire conditions Canadian Workplace Hazardous Materials Information System. TC is
could cause temporary incapacitation or possible residual injury); 3 Transport Canada. DSL/NDSL are the Canadian Domestic/Non-Domestic
(materials that can on short exposure could cause serious temporary or Substances Lists.
residual injury); 4 (materials that under very short exposure causes death or
major residual injury). Flammability Hazard and Reactivity Hazard: Refer to
definitions for 鈥淗azardous Materials Identification System鈥?.
FLEXRON MSDS
PAGE 11 OF 11
|